Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy

Nephrology

Volumn 16, Issue 6, 2011, Pages 573-581

  Advani, Andrew ^a   Wiggins, Kathryn J ^b   Cox, Alison J ^b   Zhang, Yuan ^b   Gilbert, Richard E ^a   Kelly, Darren J ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

albuminuria; diabetic nephropathy; EGF; epidermal growth factor receptor; glomerular hypertrophy

Indexed keywords

6 (4 HYDROXYPHENYL) 4 (ALPHA METHYLBENZYLAMINO) 7H PYRROLO[2,3 D]PYRIMIDINE; ANGIOTENSIN II; CELL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 1B; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; STREPTOZOCIN; WT1 PROTEIN;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; EXPERIMENTAL MODEL; FEMALE; GROWTH INHIBITION; HYPERTENSION; IMMUNOHISTOCHEMISTRY; JUXTAGLOMERULAR CELL; KIDNEY HYPERTROPHY; KIDNEY INJURY; KIDNEY SIZE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STREPTOZOCIN DIABETES;

ALBUMINURIA; ANIMALS; BIOLOGICAL MARKERS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FEMALE; HYPERTROPHY; KIDNEY; MICE; PODOCYTES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; PYRROLES; RATS; RATS, TRANSGENIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; RENIN; WT1 PROTEINS;

EID: 80051705884     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2011.01451.x     Document Type: Article

References (36)

1. Mogensen CE, Andersen MJ,. Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 1973; 22: 706-12.
2. Seyer-Hansen K,. Renal hypertrophy in streptozotocin-diabetic rats. Clin. Sci. Mol. Med. Suppl. 1976; 51: 551-5.
3. Seyer-Hansen K,. Renal hypertrophy in experimental diabetes mellitus. Kidney Int. 1983; 23: 643-6.
4. Kleinman KS, Fine LG,. Prognostic implications of renal hypertrophy in diabetes mellitus. Diabetes Metab. Rev. 1988; 4: 179-89. (Pubitemid 18085837)
5. de Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH,. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J. Am. Soc. Nephrol. 2001; 12: 993-1000. (Pubitemid 32378340)
6. Ziyadeh FN,. Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J. Am. Soc. Nephrol. 2004; 15 (Suppl 1): S55-7. (Pubitemid 38018457)
7. Sugimoto H, Shikata K, Makino H, Ota K, Ota Z,. Increased gene expression of insulin-like growth factor-i receptor in experimental diabetic rat glomeruli. Nephron 1996; 72: 648-53. (Pubitemid 26098267)
8. Gilbert RE, Cox A, McNally PG, et al,. Increased epidermal growth factor in experimental diabetes related kidney growth in rats. Diabetologia. 1997; 40: 778-85. (Pubitemid 27306955)
9. Wassef L, Kelly DJ, Gilbert RE,. Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes. Kidney Int. 2004; 66: 1805-14. (Pubitemid 41094304)
10. Kanda S, Igawa T, Sakai H, Nomata K, Kanetake H, Saito Y,. Anti-epidermal growth factor antibody inhibits compensatory renal hyperplasia but not hypertrophy after unilateral nephrectomy in mice. Biochem. Biophys. Res. Commun. 1992; 187: 1015-21.
11. Holmquist P, Torffvit O, Jorgensen PE, Torring N, Nexo E, Sjoblad S,. Early urinary changes in Tamm-Horsfall protein and epidermal growth factor in diabetic children. Pediatr. Nephrol. 2001; 16: 488-92. (Pubitemid 32515147)
12. Flyvbjerg A,. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 2000; 43: 1205-23.
13. Lautrette A, Li S, Alili R, et al,. Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach. Nat. Med. 2005; 11: 867-74. (Pubitemid 41161119)
14. Chen J, Chen JK, Neilson EG, Harris RC,. Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy. J. Am. Soc. Nephrol. 2006; 17: 1615-23. (Pubitemid 43794664)
15. Ding G, Zhang A, Huang S, et al,. ANG II induces c-Jun NH2-terminal kinase activation and proliferation of human mesangial cells via redox-sensitive transactivation of the EGFR. Am. J. Physiol. Renal Physiol. 2007; 293: F1889-97. (Pubitemid 350179613)
16. Flannery PJ, Spurney RF,. Transactivation of the epidermal growth factor receptor by angiotensin II in glomerular podocytes. Nephron Exp. Nephrol. 2006; 103: e109-18. (Pubitemid 43952616)
17. Traxler P, Bold G, Buchdunger E, et al,. Tyrosine kinase inhibitors: from rational design to clinical trials. Med. Res. Rev. 2001; 21: 499-512. (Pubitemid 32959239)
18. Advani A, Gilbert RE, Thai K, et al,. Expression, localization, and function of the thioredoxin system in diabetic nephropathy. J. Am. Soc. Nephrol. 2009; 20: 730-41.
19. Advani A, Kelly DJ, Advani SL, et al,. Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions. Proc. Natl. Acad. Sci. U S A. 2007; 104: 14448-53. (Pubitemid 350003281)
20. Hirose K, Osterby R, Nozawa M, Gundersen HJ,. Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney Int. 1982; 21: 689-95. (Pubitemid 12124298)
21. Kelly DJ, Edgley AJ, Zhang Y, et al,. Protein kinase C-beta inhibition attenuates the progression of nephropathy in non-diabetic kidney disease. Nephrol. Dial. Transplant 2009; 24: 1782-90.
22. Advani A, Kelly DJ, Cox AJ, et al,. The (Pro)renin receptor: site-specific and functional linkage to the vacuolar H+-ATPase in the kidney. Hypertension 2009; 54: 261-9.
23. Inomata S,. Renal hypertrophy as a prognostic index for the progression of diabetic renal disease in non-insulin-dependent diabetes mellitus. J. Diabetes Complications 1993; 7: 28-33. (Pubitemid 24009481)
24. Zerbini G, Bonfanti R, Meschi F, et al,. Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes. Diabetes. 2006; 55: 2620-5. (Pubitemid 44871164)
25. Rasch R, Norgaard JO,. Renal enlargement: comparative autoradiographic studies of 3H-thymidine uptake in diabetic and uninephrectomized rats. Diabetologia. 1983; 25: 280-7. (Pubitemid 13002128)
26. Kim JJ, Li JJ, Jung DS, et al,. Differential expression of nephrin according to glomerular size in early diabetic kidney disease. J. Am. Soc. Nephrol. 2007; 18: 2303-10.
27. Mullins JJ, Peters J, Ganten D,. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990; 344: 541-4.
28. Franch HA, Curtis PV, Mitch WE,. Mechanisms of renal tubular cell hypertrophy: mitogen-induced suppression of proteolysis. Am. J. Physiol. 1997; 273: C843-51.
29. Franch HA, Shay JW, Alpern RJ, Preisig PA,. Involvement of pRB family in TGF beta-dependent epithelial cell hypertrophy. J. Cell Biol. 1995; 129: 245-54.
30. Bak M, Thomsen K, Christiansen T, Flyvbjerg A,. Renal enlargement precedes renal hyperfiltration in early experimental diabetes in rats. J. Am. Soc. Nephrol. 2000; 11: 1287-92. (Pubitemid 30416225)
31. White KE, Bilous RW,. Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients. Nephrol. Dial. Transplant 2004; 19: 1437-40. (Pubitemid 38786736)
32. Menini S, Iacobini C, Oddi G, et al,. Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular disease. Diabetologia 2007; 50: 2591-9. (Pubitemid 350060642)
33. de La Motte Rouge T, Galluzzi L, Olaussen KA, et al,. A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib. Cancer Res. 2007; 67: 6253-62. (Pubitemid 47037507)
34. Ruster C, Bondeva T, Franke S, Forster M, Wolf G,. Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes. Nephrol. Dial. Transplant 2008; 23: 2179-91. (Pubitemid 351957612)
35. Chen SC, Guh JY, Hwang CC, et al,. Advanced glycation end-products activate extracellular signal-regulated kinase via the oxidative stress-EGF receptor pathway in renal fibroblasts. J. Cell Biochem. 2010; 109: 38-48.
36. Inoki K, Haneda M, Ishida T, et al,. Role of mitogen-activated protein kinases as downstream effectors of transforming growth factor-beta in mesangial cells. Kidney Int. Suppl. 2000; 77: S76-80.